Borteshil 2mg Injection

Name: Borteshil 2mg Injection
Brand: Maheshwari Medical Agency
Price: 750 INR
Availability: InStock

Price 750 INR/ Vial

Get a Price/Quote

MOQ : 4 Vials

Borteshil 2mg Injection Specification

Indication
Multiple Myeloma and Mantle Cell Lymphoma

Dosage Form
Powder

Salt Composition
Bortezomib 2mg

Enzyme Types
Proteasome Inhibitor

Feature
For intravenous or subcutaneous use only

Ingredients
Other

Application
Other

Ph Level
Neutral (reconstituted solution pH 4-7)

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits 26S proteasome activity

Storage Instructions
Keep dry & cool place

Shelf Life
24 months

Repackaging Warning
Single use only, discard unused portion

Manufactured By
La Renon Healthcare Pvt. Ltd.

Product Code
Borteshil-2mg

Registration Status
Prescription Only Medicine (Rx)

Reconstitution Solvent
Sterile 0.9% Sodium Chloride Injection

Route of Administration
Intravenous (IV) or subcutaneous (SC)

Marketed By
La Renon Healthcare Pvt. Ltd.

Preservation
No preservatives

ATC Code
L01XX32

Packaging Type
Glass vial, closed with rubber stopper and aluminum cap

Pack Size
Single dose vial

Borteshil 2mg Injection Trade Information

Minimum Order Quantity
4 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About Borteshil 2mg Injection

Spotlight on Borteshil 2mg Injection-a must-have in oncology care, now at a reduced price. Manufactured by La Renon Healthcare Pvt. Ltd., this grand, top-ranking injection contains Bortezomib, a potent proteasome inhibitor tailored for the treatment of Multiple Myeloma and Mantle Cell Lymphoma. Housed in a lavish glass vial sealed with premium closures, Borteshil's reconstitution is simple with sterile 0.9% sodium chloride. This prescription-only medicine comes as a single-use vial, ensuring safety and efficacy. Preserve in a cool, dry place for assured long shelf life.

Key Indications and Clinical Applications

Borteshil 2mg Injection is specifically indicated for the treatment of Multiple Myeloma and Mantle Cell Lymphoma. Its targeted proteasome inhibition supports crucial cancer therapeutics. Suitable for intravenous or subcutaneous administration, Borteshil ensures precise dosing for adult patients under medical supervision. Supporting both specific oncologic treatments and general therapeutic regimens, it remains an ideal choice for healthcare professionals seeking reliable clinical outcomes in eligible individuals.

Sample, Supply Chain & Certifications

Borteshil 2mg Injection samples are available upon request and dispatched promptly to verified healthcare institutions. With a dependable supply ability, we ensure that your orders are managed efficiently and professionally when a quotation is accepted. All handovers comply with established certifications and regulatory requirements, ensuring authenticity and quality throughout the distribution process for customers across India.

FAQ's of Borteshil 2mg Injection:

Q: How should Borteshil 2mg Injection be administered?

A: Borteshil 2mg Injection is administered intravenously (IV) or subcutaneously (SC) after reconstitution with sterile 0.9% sodium chloride, following precise clinical guidelines and under healthcare supervision.

Q: What are the main indications for using Borteshil 2mg Injection?

A: It is primarily indicated for patients diagnosed with Multiple Myeloma and Mantle Cell Lymphoma, as a targeted therapy to inhibit proteasome activity in cancer cells.

Q: When should the unused portion of Borteshil 2mg Injection be discarded?

A: Since Borteshil is a single-use vial with no preservatives, any leftover reconstituted solution must be discarded immediately after use to ensure safety.

Q: Where should Borteshil 2mg Injection be stored before use?

A: Store the injection in a dry, cool place, away from direct sunlight, as recommended to maintain its stability and efficacy until the expiration date.

Q: What are the benefits of choosing Borteshil 2mg Injection for eligible patients?

A: The product is a top-ranking option due to its proven efficacy, grand safety profile, and compatibility with standard clinical protocols for treated cancers.

Tell us about your requirement